Naomi L. C. Luban
Research Subjects
Naomi L. C. Luban has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Yaser Diab
Department of Hematology, Children's National Health System, Washington, DC, USA
2 shared publications - An N. Massaro
Office of Pediatric Therapeutics, Food and Drug Administration (FDA), Silver Spring, MD, USA
1 shared publication - Cassandra D. Josephson
Johns Hopkins All Children's Hospital St. Petersburg Florida USA
1 shared publication Edward C. C. Wong
Division of Laboratory Medicine Center for Cancer and Blood Disorders Children's National Medical Center The George Washington University School of Medicine and Health Sciences Washington DC USA
1 shared publication- Edward C.C. Wong
Children's National Health System, Washington DC, United States; Center for Cancer and Blood Disorders, Departments of Laboratory Medicine and Hematology, Children's National Medical Center, 111 Michigan Ave, NW, Washington DC, 20010, United States; Department of Pediatrics, George Washington University, School of Medicine and Health Sciences, Washington DC, United States; Department of Pathology, George Washington University, School of Medicine and Health Sciences, Washington DC, United States
1 shared publication - Katie R. Forman
Division of Neonatology, Department of Pediatrics, Albert Einstein College of Medicine, Children's Hospital at Montefiore, 1601 Tenbrock Avenue, 2nd Floor, Bronx, NY 10461, USA
1 shared publication
Latest Publications
- 5 April 2024
- Published by Wiley in Transfusion
- Vol. 64 (5) , 929-932
They are not just small adults
- 8 August 2016
- Published by Elsevier in Transfusion Medicine Reviews
- Vol. 30 (4) , 157-158
Pediatric and Neonatal Transfusion Medicine: A Roadmap for Research
- 8 August 2016
- Published by Elsevier in Transfusion Medicine Reviews
- Vol. 30 (4) , 157-158
Pediatric and Neonatal Transfusion Medicine: A Roadmap for Research
- Open Access
- 3 November 2014
- Published by Springer Nature in BMC Pediatrics
- Vol. 14 (1) , 277
Coagulopathy in newborns with hypoxic ischemic encephalopathy (HIE) treated with therapeutic hypothermia: a retrospective case-control study
Newborns with hypoxic ischemic encephalopathy (HIE) are at risk for coagulopathy due to systemic oxygen deprivation. Additionally, therapeutic hypothermia (TH) slows enzymatic activity of the coagulation cascade, leading to constitutive prolongation of routinely assessed coagulation studies. The level of laboratory abnormality that predicts bleeding is unclear, leading to varying transfusion therapy practices.
- 3 November 2014
- Published by Springer Nature in BMC Pediatrics
- Vol. 14 (1) , 277
Open AccessCoagulopathy in newborns with hypoxic ischemic encephalopathy (HIE) treated with therapeutic hypothermia: a retrospective case-control study
Newborns with hypoxic ischemic encephalopathy (HIE) are at risk for coagulopathy due to systemic oxygen deprivation. Additionally, therapeutic hypothermia (TH) slows enzymatic activity of the coagulation cascade, leading to constitutive prolongation of routinely assessed coagulation studies. The level of laboratory abnormality that predicts bleeding is unclear, leading to varying transfusion therapy practices.
- 21 February 2013
- Published by Wiley in British Journal of Haematology
- Vol. 161 (1) , 15-26
Massive transfusion in children and neonates
Summary: Resuscitation of children and neonates with severe or refractory bleeding due to surgery or trauma often requires massive transfusion (MT). Findings from recent studies have led to a better understanding of the complex pathophysiology in massive haemorrhage and the effects of MT on haemostasis. Current management of the massively bleeding adult patient has evolved over the past few decades, shifting to early transfusion of products in a balanced ratio as part of MT protocols (MTPs). Paediatric data on successful management of MT are limited and the optimal transfusion approach is currently unknown, leading to practice variability among institutions, depending on resource availability and patients' needs. Here, we review new important concepts in the biology of massive bleeding and MT, outline important management principles and current practices, and highlight available relevant adult and paediatric data.
- 21 February 2013
- Published by Wiley in British Journal of Haematology
- Vol. 161 (1) , 15-26
Massive transfusion in children and neonates
Summary: Resuscitation of children and neonates with severe or refractory bleeding due to surgery or trauma often requires massive transfusion (MT). Findings from recent studies have led to a better understanding of the complex pathophysiology in massive haemorrhage and the effects of MT on haemostasis. Current management of the massively bleeding adult patient has evolved over the past few decades, shifting to early transfusion of products in a balanced ratio as part of MT protocols (MTPs). Paediatric data on successful management of MT are limited and the optimal transfusion approach is currently unknown, leading to practice variability among institutions, depending on resource availability and patients' needs. Here, we review new important concepts in the biology of massive bleeding and MT, outline important management principles and current practices, and highlight available relevant adult and paediatric data.